1. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases

   • J. Bayry
   • M. Thirion
   • M. D. Kazatchkine

   BASIC STUDIES Pages: s217 - s221

2. Intravenous immunoglobulins in neurological disorders: safety issues

   • M. M. Eibl

   BASIC STUDIES Pages: s222 - s226

3. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials

   • P. S. Sørensen

   MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s227 - s230

4. Antibodies and myelination: facts and misacts

   • S. Pluchino
   • L. Zanotti
   • G. Martino

   MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s231 - s233

5. Immunoglobulin treatment of multiple sclerosis: future prospects

   • L. Durelli
   • A. Ricci
   • E. Verdun

   MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s234 - s238

6. Rasmussen’s syndrome

   • T. Granata

   MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s239 - s243

7. Infantile encephalopathies

   • G. B. Cavazzuti

   MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s244 - s245

8. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy

   • G. Comi
   • A. Quattrini
   • L. Roveri

   PERIPHERAL NEUROPATHIES Pages: s246 - s250

9. Treatment of multifocal motor neuropathy

   • E. Nobile-Orazio
   • F. Terenghi
   • A. Bersano

   PERIPHERAL NEUROPATHIES Pages: s251 - s255

10. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials

    • M. C. Dalakas

    MUSCULAR DISORDERS Pages: s256 - s259

11. Myasthenia gravis and myasthenic syndrome

    • C. Antozzi

    MUSCULAR DISORDERS Pages: s260 - s263